Choosing inhaler therapy for patients with stable COPD based on the Global Initiative for Chronic Obstructive Lung Disease grouping. Choosing inhaler therapy.

Slides:

Advertisements

Similar presentations

History Taking Zinc code: UKACL1878ea Date of preparation May 2015 AstraZeneca provided funding & reviewed for technical accuracy.

Advertisements

Respiratory medication use in Australia 2003–2013: Treatment of asthma and COPD AIHW: Correll PK, Poulos LM, Ampon R, Reddel HK and Marks GB. Published.

LSU Journal Club Withdrawal of Inhaled Glucocorticoids and Exacerbations of COPD WISDOM study H. Magnussen MD, et al. Nisha Loganantharaj, PGY1 April 21,

Date of download: 6/2/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Long-term Use of Inhaled Corticosteroids and the Risk.

Management of stable chronic obstructive pulmonary disease (2) Seminar Training Primary Care Asthma + COPD D.Anan Esmail.

GOLD 2017 major revision: Summary of key changes

Efficacy and safety of once-daily QVA149 compared with twice-daily salmeterol–fluticasone in patients with chronic obstructive pulmonary disease (ILLUMINATE):

Copyright © 2015 by the American Osteopathic Association.

Antonio Anzueto, MD, Marc Miravitlles, MD CHEST

The Role of the Primary Care Physician in Helping Adolescent and Adult Patients Improve Asthma Control Barbara P. Yawn, MD, MSc Mayo Clinic Proceedings

The Role of Fixed-Dose Dual Bronchodilator Therapy in Treating COPD

Least squares (LS) mean change from baseline (95% CI) in St George's Respiratory Questionnaire (SGRQ) Total score according to previous chronic obstructive.

Residual volume (RV) to total lung capacity (TLC) ratio versus FEV1 % predicted. Residual volume (RV) to total lung capacity (TLC) ratio versus FEV1 %

Highlights From ATS 2013: An Update on Advances in COPD

What Is the Role of Dual LAMA/LABA Bronchodilation in COPD Therapy in Light of New Clinical Data?

Volume 153, Issue 4, Pages (April 2018)

How do we critically use long-acting muscarinic receptor antagonists and beta- adrenergic receptor agonists monotherapy, or these combination therapies.

Volume 153, Issue 4, Pages (April 2018)

An Interprofessional Approach to the Patient With Chronic Airway Disease.

Severe Asthma in Primary Care: Identification and Management

Overcoming barriers to nonadherence in asthma treatment

Matrix used to calculate the kappa statistic.

Economic Burden of COPD in the Presence of Comorbidities

The distribution of the extent of change in inspiratory capacity (IC) during exercise is shown in moderate-to-severe chronic obstructive pulmonary disease.

Roflumilast negli studi di Fase III: i dati di efficacia

Example of nocturnal oxygen desaturation (NOD) and its physiological consequences. Example of nocturnal oxygen desaturation (NOD) and its physiological.

Volume 155, Issue 1, Pages e1-e4 (January 2019)

Specific therapeutic and prophylactic interventions to consider in different taxonomic groups of chronic obstructive pulmonary diseases (COPDs). Specific.

Launch of new COPD guidelines

3-year survival of lung cancer patients in the general population and in those with a prior diagnosis of chronic obstructive pulmonary disease (COPD).

Schematic overview of the suggested pharmacological management of chronic obstructive pulmonary disease (COPD). Schematic overview of the suggested pharmacological.

Benefit–risk balance and its individual determinants with personalised chronic obstructive pulmonary disease (COPD) treatment choices. Benefit–risk balance.

Inhaled bronchodilators in maintenance treatment of chronic obstructive pulmonary disease; historical evolution along the lines of evidence. Inhaled bronchodilators.

Least squares (LS) mean change from baseline (95% CI) in trough forced expiratory volume in 1 s (FEV1) according to previous chronic obstructive pulmonary.

Differences in the distribution of lung densities in a patient with ARDS on a computed tomography scan between supine position (top) and prone position.

An example of delayed cycling during pressure-support ventilation of a patient with COPD, on a Puritan Bennett 7200 ventilator, which has a flow-termination.

Example airway pressure and rib-cage impedance in a premature infant supported with the biphasic mode of SiPAP (“sigh” positive airway pressure) from the.

A: Computed tomogram shows bilateral dependent consolidation in a patient with ARDS, as well as ground-glass opacities in the non-dependent lung. A: Computed.

Diffusing capacity of the lung for carbon monoxide (DLCO) (squares) decreases with incomplete inhalations of the test gas. Diffusing capacity of the lung.

A: Machine-triggered intermittent mandatory ventilation (IMV) with inadequate patient triggering of mandatory breaths. A: Machine-triggered intermittent.

Trigger and synchronization windows.

Methods for measurement of total lung capacity (TLC) and residual volume (RV) via body plethysmography. Methods for measurement of total lung capacity.

COPD Guidelines: A Review of the 2018 GOLD Report

Schematic drawing of alveolar sizes at upper (A), middle (B), and lower dependent (C) lung regions at end expiration and end inspiration. Schematic drawing.

Bland-Altman plots of preferred – alternate method versus mean of the preferred and alternate methods for (A) residual volume (RV) for the obstructive.

Effect of respiratory mechanics on cycling of pressure support from inhalation to exhalation. Effect of respiratory mechanics on cycling of pressure support.

Correlation between inspiratory capacity (IC)/total lung capacity (TLC) ratio and oxygen pulse at peak exercise in chronic obstructive pulmonary disease.

Global Initiative for Chronic Obstructive Lung Disease (GOLD) classification based on symptom and risk evaluation. a) GOLD model of symptom/risk evaluation.

Pulse oximetry tracings from a 60-y-old woman with a COPD exacerbation who was admitted to the ICU in ventilatory failure. Pulse oximetry tracings from.

Change in mean pulmonary arterial pressure after a 5-min inhalation of the Rho kinase inhibitor Y in rats with hypoxic pulmonary hypertension, with.

Clinical findings in patients with chronic obstructive pulmonary disease according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD)

Kaplan-Meier survival curves for outcomes among COPD patients, overlap patients on CPAP, and overlap patients not on CPAP. CPAP treatment was not randomly.

Bland-Altman plots for agreements between arterial blood gas analysis and pulse oximeter measurements in subjects with COPD (A), subjects with chronic.

Gamma camera scans showing posterior lung images of 4 adult patients with cystic fibrosis following inhalation of an aerosol containing the radioisotope.

Assembly used to convert a standard ventilator to an intermittent mandatory ventilation circuit. Assembly used to convert a standard ventilator to an intermittent.

A: Changes in percent of predicted following bronchodilator for spirometric and lung volumes variables. A: Changes in percent of predicted following bronchodilator.

This figure is an example of a 14-year-old child with obstructive lung disease due to cystic fibrosis. This figure is an example of a 14-year-old child.

A: Pressure ulcer on the left cheek of a patient after 1 week of prone positioning using a commercially available endotracheal tube (ETT) holder. A: Pressure.

Mortality rate according to our integrated index that combines DH and exercise capacity. Mortality rate according to our integrated index that combines.

Flow, airway pressure, and transversus abdominis electromyogram (EMG) waveforms from a mechanically ventilated patient with COPD receiving pressure-support.

Interventional bronchoscopic and surgical treatments for chronic obstructive pulmonary disease (COPD). Interventional bronchoscopic and surgical treatments.

The Global Initiative for Chronic Obstructive Lung Disease (GOLD) ABCD scheme for classifying patients with COPD with separate appraisal of air-flow limitation.

Survival among subjects with COPD, under age 65 and with similar pulmonary function impairment, in the Nocturnal Oxygen Therapy Trial (NOTT)58 and Intermittent.

Obstructive Sleep Apnea (OSA) may overlap with any number of pulmonary diseases, including COPD, cystic fibrosis (CF), etc. Obstructive Sleep Apnea (OSA)

Representative tidal volume (VT) and breathing frequency (f) patterns of subjects with COPD and normal subjects during cardiopulmonary exercise testing.

Impedance data from patients with asthma (left) and COPD (right) according to severity of underlying disease. Impedance data from patients with asthma.

A: Comparison of pediatric lung transplant survival between different age groups. A: Comparison of pediatric lung transplant survival between different.

Average drug doses in the peripheral lung, central lung, and extrathoracic airway; residual drug left in the device; and residual drug that was exhaled.

Time taken to perform the Glittre activities of daily living (Glittre ADL) test by severity of COPD obstruction according to Global Initiative for Chronic.

Presentation transcript:

Choosing inhaler therapy for patients with stable COPD based on the Global Initiative for Chronic Obstructive Lung Disease grouping. Choosing inhaler therapy for patients with stable COPD based on the Global Initiative for Chronic Obstructive Lung Disease grouping. Treatments highlighted in green are preferred. LAMA = long-acting muscarinic antagonist; LABA = long-acting β agonist; ICS = inhaled corticosteroid. From Reference 1, with permission. Robert M Burkes, and James F Donohue Respir Care 2018;63:749-758 (c) 2012 by Daedalus Enterprises, Inc.